top of page
gradientForSurfBreak.png

Item List

Jul 1, 2025
Cision PR Newswire
SeqOnce Biosciences - Expands Their Pathogen Assay Suite with the Addition of RT-qPCR Measles Panel

SeqOnce, a company focused on the research, development, and commercialization of qPCR and NGS genomics tools for the Infectious Disease Research & CLIA Testing Market, has launched their new Measles Panel A.

Recent Posts

Portfolio Company

Carlsmed.png

Esperto Medical Awarded Grant by the Translational Research Institute for Space ...

PR Newswire

Nov 6, 2026

Portfolio Company

Carlsmed.png

Epitel's REMI™ Portal is officially live! ...

Epitel

Oct 23, 2026

Portfolio Company

Carlsmed.png

Carlsmed Launches aprevo® Lumbar Bi-lateral Posterior System ...

BioPharma Watch

Oct 14, 2026

surf break copy_edited_edited.jpg
surbreak-19.png
WM360_logo-18.png
bottom of page